Alcon Inc (ALC)
85.46
-0.04
(-0.05%)
USD |
NYSE |
Nov 21, 15:01
Alcon Price: 85.46 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 85.46 | 85.66 | 85.00 | 85.50 | 574012.0 |
| Nov 19, 2024 | 86.16 | 86.32 | 84.86 | 85.43 | 1.156M |
| Nov 18, 2024 | 84.30 | 86.86 | 84.28 | 85.81 | 1.968M |
| Nov 15, 2024 | 84.58 | 85.52 | 83.92 | 85.13 | 1.569M |
| Nov 14, 2024 | 85.90 | 86.34 | 85.16 | 85.17 | 1.238M |
| Nov 13, 2024 | 86.16 | 88.60 | 85.49 | 87.49 | 2.314M |
| Nov 12, 2024 | 91.26 | 92.16 | 85.98 | 86.89 | 3.922M |
| Nov 11, 2024 | 93.34 | 93.67 | 92.25 | 92.28 | 1.168M |
| Nov 08, 2024 | 92.46 | 92.97 | 92.26 | 92.61 | 935133.0 |
| Nov 07, 2024 | 92.73 | 93.16 | 92.33 | 92.60 | 500050.0 |
| Nov 06, 2024 | 92.08 | 92.29 | 90.49 | 91.47 | 1.114M |
| Nov 05, 2024 | 91.97 | 92.84 | 91.76 | 92.44 | 435670.0 |
| Nov 04, 2024 | 92.36 | 92.69 | 91.61 | 92.17 | 607442.0 |
| Nov 01, 2024 | 92.55 | 92.68 | 91.65 | 91.79 | 1.205M |
| Oct 31, 2024 | 92.68 | 92.76 | 91.55 | 91.95 | 607060.0 |
| Oct 30, 2024 | 93.21 | 93.96 | 93.11 | 93.27 | 895061.0 |
| Oct 29, 2024 | 94.41 | 94.76 | 94.24 | 94.51 | 345097.0 |
| Oct 28, 2024 | 94.94 | 95.14 | 94.55 | 94.87 | 523070.0 |
| Oct 25, 2024 | 94.08 | 94.71 | 93.72 | 94.25 | 407577.0 |
| Oct 24, 2024 | 94.46 | 94.74 | 94.08 | 94.39 | 420616.0 |
| Oct 23, 2024 | 94.11 | 94.65 | 93.94 | 94.51 | 301972.0 |
| Oct 22, 2024 | 94.09 | 94.74 | 93.98 | 94.64 | 429756.0 |
| Oct 21, 2024 | 94.94 | 95.17 | 94.28 | 94.34 | 502026.0 |
| Oct 18, 2024 | 94.54 | 95.52 | 94.32 | 95.14 | 604480.0 |
| Oct 17, 2024 | 95.04 | 95.19 | 94.44 | 94.52 | 502050.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
39.86
Minimum
Mar 23 2020
100.76
Maximum
Sep 12 2024
73.07
Average
73.03
Median
Apr 13 2021
Price Benchmarks
| AC Immune SA | 3.24 |
| CRISPR Therapeutics AG | 46.03 |
| Addex Therapeutics Ltd | 7.75 |
| NLS Pharmaceutics Ltd | 3.31 |
| Molecular Partners AG | 5.34 |
Price Related Metrics
| PE Ratio | 36.52 |
| PS Ratio | 4.352 |
| PEG Ratio | 0.2283 |
| Price to Book Value | 2.018 |
| Earnings Yield | 2.74% |
| Market Cap | 42.27B |
| PEGY Ratio | 0.2278 |
| Operating PE Ratio | 34.65 |
| Normalized PE Ratio | 36.52 |